Acorda Therapeutics Elects Barry Greene, COO Of (Alnylam Pharmaceuticals To Its Board Of Directors

January 8, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc® (Nasdaq: ACOR) today announced that Barry Greene, Chief Operating Officer of Alnylam Pharmaceuticals (Nasdaq: ALNY), has been elected to its Board of Directors.

Twitter
LinkedIn
Facebook
Email
Print

People

Alnylam Pharmaceuticals